Why the study?
Does antibiotic therapy and reoperation with new valve insertion successfully treat Pseudomonas aeruginosa septicemia following total aortic valve replacement?
Does antibiotic therapy and reoperation with new valve insertion successfully treat Pseudomonas aeruginosa septicemia following total aortic valve replacement?
This case report demonstrates that aggressive surgical and medical management can successfully treat severe prosthetic valve endocarditis/septicemia caused by Pseudomonas aeruginosa.
Answers are grounded in this paper and cite their sources.
Supports feasibility of aggressive reoperation plus antibiotics in Pseudomonas prosthetic endocarditis; hypothesis-generating pending prospective data.
The successful treatment of Pseudomonas aeruginosa septicemia in a 24-year-old patient by antibiotic therapy, reoperation, and insertion of a new aortic valve prosthesis three weeks after total aortic valve replacement is reported. This patient also presented other interesting features. She had a Hufnagel valve inserted for severe aortic insufficiency in December, 1955; a Teflon subcoronary, tricuspid, cage prosthesis replaced her destroyed aortic valve in April, 1960; and two Starr-Edwards aortic valve prostheses were inserted during September and October, 1963. The patient is clinically well 12 months after her last operation.
No takes yet. Share an insight, caveat, or question.
Littlefield et al. (1965) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: